Additionally, we will be focusing on broad issues that can affect commercialization so we will have major addresses from LA County Supervisor Mark Ridley-Thomas, CEO & President of LA BioMed David Meyer, NIH SBIR/STTR Program Manager J.P. Kim, Executive Director of Biocom Dina Lozofsky, Silicon Valley Bank Director of Southwest Life Sciences Brett Maver, California Life Science Association CEO Sara Radcliffe, and Larta CEO Rohit Shukla.

The program will be followed by a reception featuring posters on break-through technologies, along with a fine wine tasting hosted by LA BioMed’s President and CEO, David Meyer, PhD and our Vice President of Business Development and Technology Transfer (and Certified Sommelier), Keith Hoffman, PhD.